Viruses are small infectious agents that are incapable of reproduction outside host cells. They use the host cell's energy to synthesize proteins, DNA, and RNA. Antiviral drugs target different stages of the viral replication cycle to inhibit viral growth. Common antiviral medications include acyclovir, ganciclovir, foscarnet, and interferons. These drugs work by inhibiting viral DNA or RNA polymerase enzymes. Side effects can include nausea, vomiting, diarrhea, and organ toxicity. Antiviral therapy aims to kill viruses without harming the host cell.
2. Objectives
• Definition of virus
• Structure of virus
• Mechanism of virus replication
• Antiviral therapy
• Viral infections
• Types of viruses
• Antiviral drugs
3. Virus
• Small infective agents
• Size = 20-30nm
• Incapable of reproduction outside the host cell
• Uses the host cell’s energy for synthesis of protein, DNA & RNA
6. Antiviral Therapy
• Difficult to kill viruses
• Because they live inside the cell
• Killing the virus through drugs may kill the cell
7. Viral Infections
• IMMUNE SYSTEM
• Competent immune system kills the viruses
• Best response to viral infections
• Well functioning system effectively eliminates viral products in cell
8. Continued..
• Immuno-compromised patients have frequent viral infections
For example:
Cancer patients leukemia or lymphoma
Transplant patients immunosuppressant therapy
AIDS patients weak immune system
9.
10. DNA VIRUSES
• Poxviruses e.g. smallpox
• Herpesviruses e.g. chickenpox, shingles, cold sores,
glandular fever.
• Adenoviruses e.g. sore throat, conjunctivitis
• Papillomaviruses e.g. warts
13. AGENTS TO TREAT HERPES SIMPLEX VIRUS (HSV) &
VARICELLA-ZOSTER VIRUS (VZV) INFECTIONS
• Herpes Simplex Virus causes sores around mouth, lips (Cold sores)
and genital organs and rectum.
• Vericella Zoster virus causes chicken pox in children and adults.
• Acyclovir
• Valacyclovir
• Famciclovir
• Penciclovir
• Docosanol
• Trifluridine
14. Acyclovir
For treatment of:
• Herpes simplex virus infections
• Vericella zoster virus infections
• MECHANISM OF ACTION:
• Active form of Acyclovir metabolite inhibits viral DNA
synthesis, thus results in spreading and growth of virus.
16. Continued..
INDICATIONS
• Herpes simplex infections (cold sores)
• Vericella zoster virus infections (Chicken pox)
• Epstein Barr virus (EBV) infections.
SIDE EFFECTS
• Nausea, vomiting and diarrhea.
• Headache
• Swelling in hands and foot
• Loss of hair.
17. AGENTS TO TREAT CYTOMEGALOVIRUS (CMV)
INFECTIONS
• CMV infections include retinitis, colitis, esophagitis, central nervous
system disease, and pneumonitis.
• Ganciclovir
• Valganciclovir
• Foscarnet
• Cidofovir
18. FOSCARNET
Used for treatment of:
• Herpes simplex
• CMV infections
• Alternate therapy for HIV patients.
MECHANISM OF ACTION
Foscarnet inhibits viral DNA synthesis by inhibiting DNA polymerase
enzyme, resulting in inhibition of growth of virus in host body.
24. INTERFERONS
Interferon Alpha,
produced by virus
infected leukocytes.
Interferon Beta,
produced by virus
infected epithelial cells.
Interferon Gamma,
produced by immune
system cells in response
to antigen stimulation of
lymphocytes.
25. Interferon
Released by host cell
In response to intracellular pathogen
To alert the neighboring cells against pathogen
Leads to close of cellular protein synthesis
27. Continued..
CLINICAL USES:
• Acute and chronic Hepatitis B and C.
• Different types of cancer including Basal cell carcinoma (skin cancer),
hairy cell leukemia, chronic myloid leukemia.
• Multiple sclerosis
SIDE EFFECTS:
• Fever, malaise (general feeling of discomfort), fatigue, muscle pains.
• High levels of interferons can cause kidney, liver, bone marrow and
heart toxicity.
28. References
• 1. Reed K, Rice C. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. The
Hepatitis C Viruses: Springer; 2000. p. 55-84.
• 2. Sun SX, Wirtz D. Mechanics of enveloped virus entry into host cells. Biophysical journal. 2006;90(1):L10-L2.
• 3. Whitley RJ, Roizman B. Herpes simplex virus infections. The lancet. 2001;357(9267):1513-8.
• 4. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathmechdis Mech Dis. 2008;3:499-
522.
• 5. Kimberlin DW, Lin C-Y, Jacobs RF, Powell DA, Frenkel LM, Gruber WC, et al. Natural history of neonatal herpes simplex
virus infections in the acyclovir era. Pediatrics. 2001;108(2):223-9.
• 6. Kimberlin DW, Lin C-Y, Jacobs RF, Powell DA, Corey L, Gruber WC, et al. Safety and efficacy of high-dose intravenous
acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001;108(2):230-8.
• 7. Andersen JH, Jenssen H, Gutteberg TJ. Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit
synergy when combined with acyclovir. Antiviral research. 2003;58(3):209-15.
• 8. Maggs DJ, Clarke HE. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against
feline herpesvirus type-1. American journal of veterinary research. 2004;65(4):399-403.
• 9. Wong R, Pavesio CE, Laidlaw DAH, Williamson TH, Graham EM, Stanford MR. Acute retinal necrosis: the effects of
intravitreal foscarnet and virus type on outcome. Ophthalmology. 2010;117(3):556-60.
• 10. Sadler AJ, Williams BR. Interferon-inducible antiviral effectors. Nature reviews immunology. 2008;8(7):559.
• 11. Stewart II WE. The interferon system: Springer Science & Business Media; 2012.
• 12. Platanias LC. Mechanisms of type-I-and type-II-interferon-mediated signalling. Nature Reviews Immunology.
2005;5(5):375.
• 13. Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC, et al. Nephrectomy followed by interferon alfa-
2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. New England Journal of Medicine.
2001;345(23):1655-9.